The Californian firm, which specializes in botanical reference standards and analytical tools, already works with various groups within NIH, but said that collaboration will now be faster and more effective.
The Blanket Purchase Agreement (BPA) covers all areas of ChromaDex’s activities, including botanical reference materials, phytochemicals, bulk chemical production, analytical testing services, analytical method development, contract research, isolation of compounds, chemical synthesis and natural product libraries.
Earlier this month, ChromaDex announced it had received a $100,000 grant from the National Science Foundation to scale up a technology to develop antioxidants via fermentation.
The patented process, which the firm licensed from the University of Buffalo, uses fermentation through cell culture or recombinant organisms to produce anthocyanins, leucoanthocyanidins and anthocyanidins for use in the supplements and functional food sectors.
